Clinical trials
Completed Phase 1 Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Protara Therapeutics | 2 |
| Archivel Farma S.L. | 1 |
| BioCis Pharma Ltd | 1 |
| Eugene Lee, MD | 1 |
| Halozyme Therapeutics | 1 |
| Institut Cancerologie de l'Ouest | 1 |
| Lindis Biotech GmbH | 1 |
| Mark Dewhirst | 1 |
| Patrice Jichlinski | 1 |
| Prokarium Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 15 |
| Urinary Bladder Neoplasms | 9 |
| Carcinoma in Situ | 2 |
| Carcinoma, Transitional Cell | 1 |
| Heartburn | 1 |
| Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.